“Jeremy Earl is a trusted authority in managed care regulation, guiding insurers, PBMs and providers through the legal and commercial realities of Medicare Advantage, Medicaid managed care and value-based contracting. Known for his ability to align regulatory precision with deal momentum, he helps healthcare organisations build and defend modern managed care models at moments when scrutiny is high and stakes are higher.”

Fantastic Lawyers® Editorial, 2026

Jeremy Earl is a Partner in Washington, DC who advises a broad range of healthcare organisations on managed care law and regulation. He represents health insurers, HMOs, healthcare provider organisations, pharmacy benefit managers and administrative service providers to managed care organisations. Jeremy is a practice area leader for his firm’s Managed Care Group and serves on the firm’s Management Committee.

He is widely trusted for helping healthcare organisations structure and launch modern managed care models, including innovative value-based reimbursement arrangements and complex service relationships between health plans, providers and intermediary entities. As the line between payers and providers continues to blur, Jeremy provides strategic guidance that is grounded in the realities of the healthcare marketplace and the legal and regulatory requirements that shape it.

What Jeremy Earl Does

Jeremy advises on high-impact managed care transactions and day-to-day regulatory risk, with particular depth in requirements affecting commercial health insurance, the Medicare Advantage and Part D programs, and state Medicaid managed care programs.

His work includes joint ventures, complex service agreements and value-based and risk arrangements between payers, health systems, providers, ACOs and other value-based care entities. He also supports clients on significant regulatory disputes and litigation, including Medicare Advantage risk adjustment compliance and investigations, qui tam matters involving Medicaid managed care compliance, and class actions relating to health plan coverage policies.

Why He’s Different

Jeremy is known for combining technical regulatory strength with a commercial, deal-enabled mindset. Clients value his ability to move complex transactions forward while anticipating approval requirements and enforcement risk, and for his clear, strategic advice when scrutiny from regulators or litigants intensifies.

He has extensive experience managing regulatory approval processes for managed care transactions, including insurance department approvals, Medicare Advantage program approvals and state Medicaid agency approvals.

Representative Deal & Disputes Experience

• Represented CVS as lead health regulatory counsel in its $69 billion acquisition of Aetna, Inc.
• Represented CVS as lead health counsel in its $8 billion acquisition of Signify Health.
• Represented Prime Therapeutics in its $1.35 billion acquisition of Magellan Rx.
• Represented Prime Therapeutics in the creation of Synergie Medication Collective, a GPO launched by Blue Cross Blue Shield affiliated companies to negotiate rebates for medical benefit drugs.
• Represented Novant Health in its joint venture investment in a Medicare Advantage plan with Cone Health.
• Represented Ascension Health in its joint venture investment in a Medicare Advantage plan with Centene Corporation.
• Represented RWJBarnabas Health in its joint venture investment in Braven, a Medicare Advantage plan with Horizon BCBS and Hackensack Meridian Health.
• Represented a large integrated health system in a direct-to-employer agreement with a Fortune 500 company.
• Represent multiple Medicare Advantage plans in connection with risk adjustment audits, investigations and compliance matters.
• Successfully represented a provider-owned health insurer in a medical loss ratio audit, saving the insurer millions of dollars.
• Represented CVS as lead health counsel in the sale of its Medicare Shared Savings Program business of CVS Accountable Care to Wellvana.
• Represented Medicare Advantage insurer Alignment Health Plan in challenging its Star Rating from CMS.

Thought Leadership

Jeremy is a frequent speaker at national healthcare industry conferences and is regularly quoted in healthcare trade and national publications, including HealthPayer Intelligence, Modern Healthcare, Managed Care Executive, Business Insurance and Vox.com.

Recognition & Trust Signals

Jeremy is recognised as a leading lawyer in Legal 500 US for Healthcare: Health Insurers (2022–2025). He is also listed in Best Lawyers in America for Healthcare Law (2023–2026) and has been named a Thomson Reuters Stand-out Lawyer (2024–2026). He has also been recognised by the American Health Lawyers Association as a Pro Bono Champion (2012–2014).

Credentials

Jeremy earned his JD from Duke University School of Law (2009) and his BA from the University of St. Thomas, summa cum laude (2006). He is admitted in California and the District of Columbia.

Location

Jeremy Earl is based in Washington, DC and advises healthcare organisations nationwide on managed care regulation, transactions and enforcement risk.